• Wed news: 2025 Medicare drug price negotiations. BioAge Labs aiming at $180M IPO. Merck Keytruda colorectal cancer flop. Sanofi gets bids for consumer health unit. Novo Nordisk CEO in Senate hot seat. See more on our front page

Valeant To Sell Filler And Toxin Assets To Nestle For $1.4 Billion


<







another indication that the deal is done is today's AGN stock prices ...

all the short term interest is running away

institutionals and hedgies are coming in who will sell to VRX